title: [Modulation of immune response by bacterial lipopolysaccharides].
abstract: Lipopolysaccharide (LPS) is a molecule that is profusely found on the outer membrane of Gram-negative bacteria and is also a potent stimulator of the immune response. As the main molecule on the bacterial surface, is also the most biologically active. The immune response of the host is activated by the recognition of LPS through Toll-like receptor 4 (TLR4) and this receptor-ligand interaction is closely linked to LPS structure. Microorganisms have evolved systems to control the expression and structure of LPS, producing structural variants that are used for modulating the host immune responses during infection. Examples of this include Helicobacter pylori, Francisella tularensis, Chlamydia trachomatis and Salmonella spp. High concentrations of LPS can cause fever, increased heart rate and lead to septic shock and death. However, at relatively low concentrations some LPS are highly active immunomodulators, which can induce non-specific resistance to invading microorganisms. The elucidation of the molecular and cellular mechanisms involved in the recognition of LPS and its structural variants has been fundamental to understand inflammation and is currently a pivotal field of research to understand the innate immune response, inflammation, the complex host-pathogen relationship and has important implications for the rational development of new immunomodulators and adjuvants.
authors: Instituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Hospital de Especialidades, Unidad de Investigación Médica en Inmunoquímica, Ciudad de México, México. constantino@sminmunologia.mx.
authors: Gustavo
authors: G
authors: Aldapa-Vega
authors: Rodolfo
authors: R
authors: Pastelín-Palacios
authors: Armando
authors: A
authors: Isibasi
authors: Mario A
authors: MA
authors: Moreno-Eutimio
authors: Constantino
authors: C
authors: López-Macías
mesh_terms: D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D001424:Bacterial Infections / Q000276:immunology*; D002692:Chlamydia trachomatis / Q000276:immunology; D005604:Francisella tularensis / Q000276:immunology; D016480:Helicobacter pylori / Q000276:immunology; D006801:Humans; D007113:Immunity, Innate; D008070:Lipopolysaccharides / Q000276:immunology* / Q000378:metabolism; D012475:Salmonella / Q000276:immunology; D051197:Toll-Like Receptor 4 / Q000276:immunology
chemical_list: D000276:Adjuvants, Immunologic; D008070:Lipopolysaccharides; D051197:Toll-Like Receptor 4
keywords: Immunomodulation; Lipopolysaccharide; Toll-like receptor 4